Surface Oncology to Present Clinical Updates for SRF388 and SRF617

In conjunction, Surface will host a webcast on Friday, June 4, 2021 at 8:00 a.m. to review the SRF388 clinical data as well as to provide a clinical update from the company\xe2\x80\x99s ongoing SRF617 Phase 1 study.\n\xe2\x80\x9cWe\xe2\x80\x99re excited to share clinical data on our lead therapeutic candidates, both of which are first-in-class,\xe2\x80\x9d said Alison O\xe2\x80\x99Neill, M.D., chief medical officer at Surface Oncology.